U.S. Healthtech Stock News

If you are looking at Deckers Outdoor and wondering whether the current share price lines up with the underlying business, this article will walk you through the key valuation angles to help you frame that question. The stock last closed at US$118.17, with returns of 2.1% over the past week, 18.2% over the last 30 days, 10.7% year to date, but a 15.7% decline over the last year. The 3 year and 5 year returns sit at 74.5% and 113.9% respectively. Recent market attention on Deckers Outdoor has...

Why Chevron is on investors’ radar today Chevron (CVX) is back in focus after recent share price moves, with the stock last closing at US$184.91. For investors, the interest now is how that price stacks up against the company’s fundamentals. See our latest analysis for Chevron. Recent trading has been positive, with a 10.91% 1 month share price return adding to an 18.61% year to date move and a 22.38% 1 year total shareholder return. This suggests that momentum has been building rather than...

Mastercard (MA) shares have been caught up in a sector wide pullback after a Citrini Research report on artificial intelligence risks to payment fees and enterprise software prompted investors to reassess exposure to payment networks. See our latest analysis for Mastercard. At a share price of US$496.03, Mastercard is now sitting below recent highs, with a 1 day share price return of 5.77% decline and a 90 day share price return of 9.23% decline, suggesting momentum has cooled even as recent...

NNN REIT has confirmed that Board Chairperson Steven D. Cosler retired on February 18, 2026, after nearly a decade of service, and independent director Edward J. Fritsch, an experienced REIT leader and former Highwoods Properties CEO, was appointed to succeed him. Fritsch’s long tenure on NNN’s board and his industry leadership roles at Highwoods and Nareit suggest continuity in governance and deep sector expertise at the helm. With Edward Fritsch now chairing the board, we’ll examine how...

Ultragenyx Pharmaceutical (RARE) is back in focus after the U.S. FDA accepted its Biologics License Application for DTX401, a gene therapy candidate for Glycogen Storage Disease Type Ia, and granted it Priority Review. See our latest analysis for Ultragenyx Pharmaceutical. The FDA Priority Review comes after a volatile period for Ultragenyx, with the latest share price at $22.51 and a 7-day share price return of 9.7% contrasting with a 90-day share price return of a 32.9% decline and a 1-year...

Casella Waste Systems (NasdaqGS:CWST) has completed nine acquisitions, adding more than $115 million in annualized revenues. The company outlined an active pipeline of additional deals it aims to pursue in 2026. Management framed the acquisition push as a key lever for scaling operations and driving efficiencies across the business. For investors following NasdaqGS:CWST, this deal streak comes at a time when the stock is trading at $92.71 and has seen a 17.2% decline over the past year,...

Comcast (CMCSA) is back in focus after highlighting progress on several fronts, including a quantum computing trial to support network reliability, fresh content spending for Peacock, and continued broadband build outs in underserved communities. See our latest analysis for Comcast. Those quantum trials, Peacock sports spending and fresh broadband builds come as Comcast shares trade at $31.63, with a 30 day share price return of 7.95% and a 90 day gain of 18.55%, while the 1 year total...

Talen Energy recently secured a long-term agreement to supply carbon-free nuclear power from its Pennsylvania plant to Amazon Web Services' data center campus, supported by management’s reaffirmed 2026 Adjusted EBITDA guidance of US$1.75–US$2.05 billion and planned expansion of its gas-fired generation fleet. This combination of a multibillion-dollar, blue-chip contract and growth-focused capacity additions underscores how hyperscale data center demand is reshaping Talen’s power mix and...

Conagra Brands (CAG) is back on investors’ radar after recent trading left the shares at $18.86, with mixed short term performance that includes a modest gain over the past month and the past 3 months. See our latest analysis for Conagra Brands. That recent 1 month share price return of 7.77% and 3 month gain of 6.31% sits against a 1 year total shareholder return decline of 21.46%. This combination suggests some short term momentum, while longer term holders are still under pressure. If...

Dream Finders Homes (DFH) just wrapped up FY 2025 with Q4 revenue of US$1.2b and basic EPS of US$0.63 on net income of US$58.7m. The trailing twelve months show revenue of US$4.3b and EPS of US$2.33 on net income of US$217.2m. Over recent quarters, the company has seen revenue range from US$969.8m to US$1.2b, with quarterly EPS moving between US$0.47 and US$0.63. This puts the latest print in the context of a fairly active year for both top and bottom line. For investors, the key question now...

Wondering if Tapestry is still good value after its recent run, or if the price has moved ahead of the story? This article will walk you through what the current share price might be implying. The stock closed at US$152.97, with a 7 day return of a 0.5% decline, a 30 day return of 17.6%, an 18.5% return year to date, an 84.2% return over 1 year, and a 284.1% return over 3 years, while the 5 year return stands at 317.3%. Recent attention on Tapestry has centered on its role in the consumer...

On 17 February 2026, Fortrea Holdings expanded its executive team by dedicating Oren Cohen, MD solely to the chief medical officer role and appointing Scott Dove, PhD as president of Clinical Pharmacology Services, with both serving on the Executive Committee. This leadership reshaping concentrates seasoned medical and early development expertise at the top of the organization, potentially affecting how Fortrea runs trials and manages its clinical pharmacology operations. Next, we’ll examine...

In February 2026, Teradyne participated in the Chiplet Summit at the Santa Clara Convention Center, where Nitza Basoco and Jeorge Hurtarte presented on the company’s chiplet and AI-focused test technologies. These presentations, alongside Teradyne’s expansion in AI-oriented Semiconductor Test solutions through acquisitions and joint ventures, underscore how central AI data center and silicon photonics testing have become to its business profile. We’ll now examine how Teradyne’s push into...

Revvity (RVTY) drew investor attention after recent trading left the stock down about 18% over the past month and 8% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Revvity. That recent 30 day share price return of a 16.8% decline, alongside a 15.2% decline in the 1 year total shareholder return and a 24.3% decline over 5 years, suggests sentiment has been fading despite the latest close at $97.12. If Revvity's recent swings have you...

Wondering if Jack Henry & Associates at around US$155.68 is offering fair value or an opportunity is common, and many investors are asking whether the current price really reflects what the business is worth. The stock has seen a 0.6% decline over the past week, a 15.9% decline over the past month and is down 12.7% year to date, with a 1 year return of 8.6%, a 3 year return of 2.3% and a 5 year return of 8.9%. Recent news coverage has largely focused on Jack Henry & Associates as an...

Earlier in February 2026, Bright Horizons Family Solutions reported fourth-quarter 2025 results showing sales of US$733.7 million and full-year 2025 revenue of US$2.93 billion, alongside earnings per share from continuing operations of US$3.36 on a diluted basis. The company also issued fiscal 2026 revenue guidance of US$3.08–US$3.13 billion and highlighted continued strength in its back-up care segment and improving profitability in its U.K. operations, underscoring management’s focus on...

Saia (NasdaqGS:SAIA) is facing ongoing sales volume challenges over the last two years and has leaned on price increases to support revenue. At the same time, the company has stepped up investment activity, which has pressured cash flows. Returns on capital have declined, raising questions about whether Saia’s traditional profit drivers are maturing. Saia operates in the less than truckload freight sector, where pricing power and network efficiency matter as much as demand trends. For you...

Generac Holdings (GNRC) has caught investor attention after a strong recent share price run, with gains over the past month and the past 3 months, putting fresh focus on its fundamentals and valuation. See our latest analysis for Generac Holdings. At a latest share price of $227.45, Generac’s strong 30 day share price return of 31.47% and 90 day share price return of 53.10% contrast with a weaker 5 year total shareholder return of a 34.31% decline, suggesting momentum has recently picked up...

In February 2026, Quanta Services reported record fourth-quarter and full-year 2025 results, with full-year sales of US$28.48 billion and net income of US$1.03 billion, and issued 2026 guidance calling for revenues between US$33.25 billion and US$33.75 billion and net income between US$1.27 billion and US$1.38 billion. The company also highlighted a record US$44 billion backlog, eight acquisitions in 2025, and plans to invest US$500 million to US$700 million in transformer manufacturing,...

CME Group has recently announced plans to begin 24/7 trading of its cryptocurrency futures and options on CME Globex from May 29, 2026, pending regulatory approval, alongside several new product launches across single-stock, rare earths, digital asset, and agricultural derivatives. The company also lifted its regular quarterly dividend to US$1.30 per share and is broadening its reach into South Asia edible oils and newer crypto assets, underscoring how product breadth and around-the-clock...

In recent weeks, Meta Platforms has expanded its AI footprint through a multiyear Nvidia infrastructure partnership, a more than US$10.00 billion, 1‑gigawatt Indiana data center project, and the declaration of a US$0.525 quarterly dividend payable in March 2026. At the same time, Meta is tightening internal costs, reviving AI-driven wearables, and attracting high-profile hedge fund backing, underscoring a broad pivot from metaverse spending toward large-scale, monetizable AI capabilities...

Cisco and SharonAI Holdings have launched Australia’s first Cisco Secure AI Factory with NVIDIA, powered by 1,024 NVIDIA Blackwell Ultra GPUs and Cisco’s networking and security stack to deliver sovereign, high‑performance AI infrastructure with all data and processing kept onshore. This “AI factory” model, alongside NVIDIA’s expanding data center deployments in India and other regions, highlights how sovereign and hyperscale AI buildouts are embedding NVIDIA hardware and software at the...

Pegasystems Inc. has reported past fourth-quarter 2025 revenue of US$504.32 million and full-year revenue of US$1.75 billion, alongside materially higher profitability, and it has completed a long-running share repurchase program totaling 26,643,656 shares for US$863.54 million. At the same time, Pegasystems issued 2026 guidance calling for US$2.0 billion in GAAP revenue and GAAP diluted earnings per share of US$1.87, while its stock moved in the opposite direction amid wider software-sector...

Datadog (NasdaqGS:DDOG) used its recent Investor Day to outline new steps in autonomous observability and AI centric capabilities across its platform. The company spotlighted agentic and AI native use cases, along with fresh disclosures on Security customer adoption and AI usage metrics. Management framed these updates as part of an ongoing shift toward AI driven observability and security services for cloud workloads. Datadog runs a cloud based observability and security platform that...